PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
33976256-0	2021	IDH2 mutations in patients with normal karyotype AML predict favorable responses to daunorubicin, cytarabine and cladribine regimen.	Daunorubicin	84-96	isocitrate dehydrogenase (NADP(+)) 2	Homo sapiens	0-4